VENUS MEDTECH-B (02500), Hangzhou Gaoxin Materials Technology, and Hangzhou Yingzhiqin have established an investment terms list.

VENUS MEDTECH-B(02500) announced that on July 1, 2026, the company, Hangzhou Gaoxin Materials Technology, and Hangzhou Yingzhiqin have entered into an investment terms list. According to this list, Hangzhou Gaoxin Materials Technology and Hangzhou Yingzhiqin express their intention to invest in the company along with other potential investors through potential transactions (including potential share subscription and potential convertible bond subscription), with a total investment amount of up to RMB 500 million. According to the investment terms list, it is suggested that interested investors should invest in the company through subscribing for new shares. The subscription price for each new share is 100% of the average closing price of the shares reported on the Stock Exchange of Hong Kong for the last 20 consecutive trading days before the formal trading document is signed, but not exceeding HK$2.5 per share. According to the investment terms list, it is suggested that interested investors should invest in the company through subscribing for new convertible bonds. The conversion price of the new convertible bonds is 110% of the average closing price of the shares reported on the Stock Exchange of Hong Kong for the last 20 consecutive trading days before the formal trading document is signed, but not exceeding HK$2.5 per share.